injection site soreness semaglutide reactions: treatment and prevention The 3 Most Common GLP-1

Weintraub M, Sundaresan PR, Schuster B, Averbuch M, Stein EC, Byrne L

Possible complications related to GLP-1 use under anesthesia include: Aspiration due to delayed gastric emptying Hemodynamic instability: pronounced hypotension or bradycardia Altered response to opioids and sedatives, requiring dose changes Perioperative hypoglycemia from additive glucose-lowering effects Nausea and vomiting increasing postoperative airway risk Delayed recovery of bowel function, affecting discharge timing Interference with regional anesthesia sympathetic block assessment Post-Surgery Restart Post-surgery restart of GLP-1 receptor agonists should be done with clear criteria and close coordination to avoid complications and maintain therapeutic goals

No side effects or complications were reported in this study

A Health Canada spokesperson told Global News in an email on Wednesday evening that the agency was aware of the recent FDA alert and was actively monitoring safety information received from multiple sources, including international regulators. As of July 29, 2024, Health Canada has not received adverse reaction reports relating to dosing errors in which it is specified that the suspect product is a compounded injectable semaglutide product, spokesperson Mark Johnson said

If you have an implant or hormonal IUS and do still experience regular bleeds, please speak with a GP or sexual health clinician rather than self-treating

Your provider should be your partner, not an obstacle